Medicis Pharmaceutical Corp. (MRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.24 -0.56%
Revenue Growth %: +21.2%
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +21.2%
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q3 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $484.6 million versus the consensus estimate of $475.84 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
- General Mills (GIS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
